Calidi (CLDI) Biotherapeutics announced the succession of its Chief Executive Officer, Allan Camaisa, to Eric Poma, Ph.D., who was appointed as CEO and member of the Board of Directors of Calidi, effective April 22, 2025. Camaisa will continue to serve as a member of the Board.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDI:
- Calidi announces FDA clearance of IND application for CLD-201
- Calidi appoints Guy Travis Clifton as CMO, Consultant, Advisor
- Calidi Biotherapeutics Appoints New Chief Medical Officer
- Calidi Biotherapeutics Reports 2024 Financial Results and Progress
- Calidi reports Q4 EPS Q4 EPS (27c) vs (23c) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue